Getagraph.com logo
S&P 500
(0.18%) 5 109.13 points
Dow Jones
(0.28%) 38 346 points
Nasdaq
(0.22%) 15 963 points
Oil
(-1.31%) $82.75
Gas
(6.34%) $2.05
Gold
(-0.09%) $2 345.20
Silver
(-0.27%) $27.46
Platinum
(3.93%) $958.35
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.33%) $10.99
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.66%) $93.40

Sanntidsoppdatering for Zymeworks Inc [ZYME]

Børs: NYSE Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(amc 2024-05-02)

Expected move: +/- 5.56%

Sist oppdatert29 apr 2024 @ 21:51
25% discount on Stockinvest.us - Use code: Podcast

0.85% $ 8.33

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 21:51):

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors...

Stats
Dagens volum 189 023
Gjennomsnittsvolum 578 170
Markedsverdi 587.83M
EPS $0 ( 2024-03-06 )
Neste inntjeningsdato ( $-0.310 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.84
ATR14 $0.0120 (0.14%)
Insider Trading
Date Person Action Amount type
2024-04-02 Gallagher Neil Buy 74 000 Stock Option (Right to Buy)
2024-04-02 Gallagher Neil Sell 0 No securities are beneficially owned
2024-02-22 Platshon Scott Buy 0
2024-02-08 Cesano Alessandra Buy 74 000 Stock Option (Right to Buy)
2024-02-08 Cesano Alessandra Sell 0 No securities are beneficially owned
INSIDER POWER
94.06
Last 71 transactions
Buy: 13 173 358 | Sell: 322 010

Volum Korrelasjon

Lang: -0.32 (neutral)
Kort: 0.68 (moderate)
Signal:(56.168) Neutral

Zymeworks Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Zymeworks Inc Korrelasjon - Valuta/Råvare

The country flag -0.29
( neutral )
The country flag -0.41
( neutral )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag -0.36
( neutral )
The country flag 0.68
( moderate )

Zymeworks Inc Økonomi

Annual 2023
Omsetning: $76.01M
Bruttogevinst: $-66.98M (-88.11 %)
EPS: $-1.720
FY 2023
Omsetning: $76.01M
Bruttogevinst: $-66.98M (-88.11 %)
EPS: $-1.720
FY 2022
Omsetning: $412.48M
Bruttogevinst: $203.78M (49.40 %)
EPS: $1.910
FY 2021
Omsetning: $26.68M
Bruttogevinst: $0.00 (0.00 %)
EPS: $-4.11

Financial Reports:

No articles found.

Zymeworks Inc

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc. It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.